[1]
Rida Zainab, “A Randomized Trial of miRNA-34a-Based Therapy for Chemosensitization in Triple-Negative Breast Cancer Patients”, JHWCR, vol. 4, no. 5, pp. 1–7, Mar. 2026, doi: 10.61919/hxwqyv32.